Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia: A case report

Mayur D. Mody, Deepak Ravindranathan, Harpaul S. Gill, Vamsi K. Kota

Research output: Contribution to journalArticle

1 Scopus citations


Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Issue number1
Publication statusPublished - Jan 1 2017
Externally publishedYes



  • AML
  • Acute myeloid leukemia
  • Posaconazole
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Cite this